Thomas A. Kelly

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

A. Michael Lincoff, Robert M. Califf, David J. Moliterno et al. · New England Journal of Medicine · 1999 · 379 citations

Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction

Bruce R. Brodie, Thomas Stuckey, Thomas C. Wall et al. · Journal of the American College of Cardiology · 1998 · 329 citations

Percutaneous Coronary Intervention, Heart Failure, Cardiogenic Shock +9

Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis

Thomas A. Kelly, Robert M. Rothbart, C.Morgan Cooper et al. · The American Journal of Cardiology · 1988 · 305 citations

Cardiovascular Disease, Symptomatic Patients, Vascular Surgery +9

Sustained Suppression of Ischemic Complications of Coronary Intervention by Platelet GP IIb/IIIa Blockade With Abciximab

A. Michael Lincoff, James E. Tcheng, Robert M. Califf et al. · Circulation · 1999 · 157 citations

Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy

Bruce R. Brodie, Richard A. Weintraub, Thomas Stuckey et al. · The American Journal of Cardiology · 1991 · 121 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +10